1. Fenretinide treatment in APOE-KO mice severely alters erythrocyte turnover and causes a dramatic increase of circulating leukocytes resulting in a worsened atherosclerosis development. (December 2020) Authors: Busnelli, M.; Manzini, S.; Bonacina, F.; Colombo, A.; Soldati, S.; Barbieri, S.S.; Amadio, P.; Sandrini, L.; Arnaboldi, F.; Donetti, E.; Laaksonen, R.; Paltrinieri, S.; Scanziani, E.; Chiesa, G. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Prenylcysteine oxidase 1, A novel player in atherosclerosis. (August 2021) Authors: Banfi, C.; Baetta, R.; Barbieri, S.S.; Brioschi, M.; Guarino, A.; Ghilardi, S.; Sandrini, L.; Polvani, G.; Bergman, O.; Eriksson, P.; Tremoli, E. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗